Cargando…
A quantitative analysis of statistical power identifies obesity endpoints for improved in vivo preclinical study design
The design of well-powered in vivo preclinical studies is a key element in building knowledge of disease physiology for the purpose of identifying and effectively testing potential anti-obesity drug targets. However, as a result of the complexity of the obese phenotype, there is limited understandin...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568066/ https://www.ncbi.nlm.nih.gov/pubmed/28392555 http://dx.doi.org/10.1038/ijo.2017.93 |